Although the emergence of antimicrobial “superbugs” and the paucity of new medicines being developed to combat them is a global problem, circumstances in developing countries raise particular concerns. For those with health care systems that are already overloaded treating or protecting individuals from diseases such as tuberculosis and malaria, confronting the issue of antimicrobial resistance is a lower priority. That lower priority allows such practices as inappropriate use of antibiotics for human and animal health and inadequate measures to control the spread of infections to promote the development of resistant strains of microbes.
Mitka M. Indian Public Health Leaders Move to Reduce Antimicrobial Resistance. JAMA. 2013;309(6):531-532. doi:10.1001/jama.2013.297